1. Home
  2. AEHR vs ABUS Comparison

AEHR vs ABUS Comparison

Compare AEHR & ABUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aehr Test Systems

AEHR

Aehr Test Systems

HOLD

Current Price

$35.58

Market Cap

858.8M

Sector

Industrials

ML Signal

HOLD

Logo Arbutus Biopharma Corporation

ABUS

Arbutus Biopharma Corporation

HOLD

Current Price

$4.57

Market Cap

884.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AEHR
ABUS
Founded
1977
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
858.8M
884.7M
IPO Year
1997
2008

Fundamental Metrics

Financial Performance
Metric
AEHR
ABUS
Price
$35.58
$4.57
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$21.00
$5.00
AVG Volume (30 Days)
1.6M
2.1M
Earning Date
04-08-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
13.64
EPS
N/A
N/A
Revenue
$58,968,000.00
$6,171,000.00
Revenue This Year
N/A
$125.30
Revenue Next Year
$60.20
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.27
$2.71
52 Week High
$46.95
$5.10

Technical Indicators

Market Signals
Indicator
AEHR
ABUS
Relative Strength Index (RSI) 52.61 56.60
Support Level $20.22 $4.18
Resistance Level N/A $4.69
Average True Range (ATR) 4.34 0.24
MACD 0.20 0.05
Stochastic Oscillator 46.06 75.57

Price Performance

Historical Comparison
AEHR
ABUS

About AEHR Aehr Test Systems

Aehr Test Systems is engaged in test systems for burning-in and testing logic, optical, and memory integrated circuits. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets. The Company operates in one business segment, the designing, manufacturing, marketing and selling of advanced test and burn-in products to the semiconductor manufacturing industry in several geographic areas. The company provides production solutions across the product manufacturing flow to improve yield and reliability and has developed and introduced several inventive products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier and FOX DiePak Loader.

About ABUS Arbutus Biopharma Corporation

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.

Share on Social Networks: